A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS) - PubMed (original) (raw)
Review
A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS)
Arezoo Moini Jazani et al. Daru. 2019 Dec.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a frequent medical condition characterized by both metabolic and reproductive disorders. Different pharmaceutical treatments have been proposed for PCOS. However, side effects of long-term treatments and their probable low efficacy have made complementary and alternative treatments a valuable option. Recent reports have indicated the increased use of complementary treatments. Herbal medicine, as part of complementary medicine, was find introduced in traditional Persian and Chinese medicine. Medicinal herbs have used for a long time in the treatment of gynecological and infertility problems of PCOS patients. In this study, we aimed to review herbal medicines used for PCOS worldwide.
Methods: PubMed, Embase, Cochrane, and Scopus databases were searched for clinical trials and Randomized Controlled Trials based on related keywords. Data were collected from 1990 to 2019.
Results: According to a multitude of studies, a wide spectrum of herbs can be used to improve various aspects of PCOS. Herbs such as Cinnamomum verum, Trigonella foenum-graecum L., and Vitex agnus-castus can impact on menstrual and ovulatory dysfunctions, obesity, insulin resistance, lipid-metabolism dysfunction, and androgen excess-related conditions.
Conclusion: Some plants as natural remedies may have beneficial effects on improving different aspects of PCOS; but further studies are needed to investigate their mechanisms and safety.
Keywords: Complementary medicine; Herbal medicine; PCOS; Polycystic ovary syndrome.
Conflict of interest statement
The authors declare no conflict of interest or financial relationships.
Figures
Fig. 1
Flow diagram of the study selection process
Similar articles
- Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S, Abbott JA, Smith CA, Bensoussan A. Arentz S, et al. BMC Complement Altern Med. 2014 Dec 18;14:511. doi: 10.1186/1472-6882-14-511. BMC Complement Altern Med. 2014. PMID: 25524718 Free PMC article. Review. - The Role of medicinal herbs in treatment of insulin resistance in patients with Polycystic Ovary Syndrome: A literature review.
Ashkar F, Rezaei S, Salahshoornezhad S, Vahid F, Gholamalizadeh M, Dahka SM, Doaei S. Ashkar F, et al. Biomol Concepts. 2020 Mar 26;11(1):57-75. doi: 10.1515/bmc-2020-0005. Biomol Concepts. 2020. PMID: 32229652 Review. - Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Ong M, Peng J, Jin X, Qu X. Ong M, et al. Am J Chin Med. 2017;45(3):405-422. doi: 10.1142/S0192415X17500252. Epub 2017 Mar 30. Am J Chin Med. 2017. PMID: 28359195 Review. - Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis.
Arentz S, Smith CA, Abbott J, Bensoussan A. Arentz S, et al. BMC Complement Altern Med. 2017 Nov 25;17(1):500. doi: 10.1186/s12906-017-2011-x. BMC Complement Altern Med. 2017. PMID: 29178904 Free PMC article. Review. - Polycystic ovaries and herbal remedies: A systematic review.
Manouchehri A, Abbaszadeh S, Ahmadi M, Nejad FK, Bahmani M, Dastyar N. Manouchehri A, et al. JBRA Assist Reprod. 2023 Mar 30;27(1):85-91. doi: 10.5935/1518-0557.20220024. JBRA Assist Reprod. 2023. PMID: 35916457 Free PMC article. Review.
Cited by
- Dietary supplements in polycystic ovary syndrome-current evidence.
Han Y, Hou Y, Han Q, Yuan X, Chen L. Han Y, et al. Front Endocrinol (Lausanne). 2024 Sep 27;15:1456571. doi: 10.3389/fendo.2024.1456571. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39398335 Free PMC article. Review. - Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs.
Malik S, Saeed S, Saleem A, Khan MI, Khan A, Akhtar MF. Malik S, et al. Front Endocrinol (Lausanne). 2024 Jan 11;14:1294406. doi: 10.3389/fendo.2023.1294406. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38725974 Free PMC article. Review. - Exploring the Antioxidative Effects of Ginger and Cinnamon: A Comprehensive Review of Evidence and Molecular Mechanisms Involved in Polycystic Ovary Syndrome (PCOS) and Other Oxidative Stress-Related Disorders.
Novakovic S, Jakovljevic V, Jovic N, Andric K, Milinkovic M, Anicic T, Pindovic B, Kareva EN, Fisenko VP, Dimitrijevic A, Joksimovic Jovic J. Novakovic S, et al. Antioxidants (Basel). 2024 Mar 25;13(4):392. doi: 10.3390/antiox13040392. Antioxidants (Basel). 2024. PMID: 38671840 Free PMC article. Review. - Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review).
Raihanah C, Sukrasno S, Kurniati NF. Raihanah C, et al. Biomed Rep. 2024 Mar 21;20(5):80. doi: 10.3892/br.2024.1768. eCollection 2024 May. Biomed Rep. 2024. PMID: 38590945 Free PMC article. Review. - LncRNA SNHG12 promotes cell proliferation and inhibits apoptosis of granulosa cells in polycystic ovarian syndrome by sponging miR-129 and miR-125b.
Xuan F, Jin R, Zhou W, Ye Y, Ren Y, Lu J, Chen A. Xuan F, et al. J Ovarian Res. 2024 Apr 2;17(1):72. doi: 10.1186/s13048-024-01392-6. J Ovarian Res. 2024. PMID: 38566229 Free PMC article.
References
- Eshre TR, Asrm-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. - PubMed
- Ozcan Dag Z, Alpua M, Isik Y, Buturak SV, Tulmac OB, Turkel Y. The evaluation of temperament and quality of life in patients with polycystic ovary syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2017;33(3):250–253. - PubMed
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855. - PubMed
- Celik O, Acbay O. Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance. J Endocrinol Investig. 2012;35(10):905–910. - PubMed
- Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–697. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical